Glioma

Fluorescence Can ID High-Grade Glioma During Sx for Brain Tumor

Fluorescence Can ID High-Grade Glioma During Sx for Brain Tumor

The presence of visible fluorescence can serve as an intraoperative diagnostic surgical biomarker of high-grade glioma within a brain tumor.

Temozolomide Plus Radiotherapy Improves Survival in Non-Co-Deleted Glioma

Temozolomide Plus Radiotherapy Improves Survival in Non-Co-Deleted Glioma

By

1p/19q non-co-deleted anaplastic gliomas are associated with lower sensitivity to chemotherapy and worse prognosis than 1p/19q co-deleted tumors.

Researchers Debunk Rumored Link Between Glioblastoma, Cytomegalovirus

Researchers Debunk Rumored Link Between Glioblastoma, Cytomegalovirus

Despite previous reports, researchers have found no signs of a link between cytomegalovirus and brain tumors including glioblastoma.

Radiomic Method Helps Predicts Glioblastoma Outcome

Radiomic Method Helps Predicts Glioblastoma Outcome

Radiomic-based superpc signature stratifies patients into low- or high-risk groups for PFS, OS.

In Glioblastoma, Personalized Medicine is a Challenge

In Glioblastoma, Personalized Medicine is a Challenge

By

The role of antiangiogenic agents continues to evolve in the treatment of CNS cancers.

Glioma Signature Predicts Outcomes in Glioblastoma

Glioma Signature Predicts Outcomes in Glioblastoma

By

Researchers were able to identify 8 genes that showed the highest association to outcomes.

Combined Modality Therapy Superior in Glioblastoma

Combined Modality Therapy Superior in Glioblastoma

By

Multiple modalities were found to be superior to single modality therapies in elderly patients with glioblastoma.

Valproic Acid Beneficial in Glioblastoma, But Not Low-Grade Glioma

Valproic Acid Beneficial in Glioblastoma, But Not Low-Grade Glioma

By

Interestingly, the risk of death and tumor progression was increased in low-grade gliomas.

Chemo Plus Radiation May Extend Survival in Grade 2 Glioma

Chemo Plus Radiation May Extend Survival in Grade 2 Glioma

Those who received both treatments lived longer than those who received radiation alone.

Brain Tumor Histology and Incidence in Adolescents and Young Adults

Brain Tumor Histology and Incidence in Adolescents and Young Adults

By

Over 10 000 brain and CNS tumors are diagnosed in adolescent and young adults each year.

Does Rosacea Increase the Risk of Glioma?

Does Rosacea Increase the Risk of Glioma?

The association may be mediated by mechanisms dependent on matrix metalloproteinases.

Obesity, Physical Activity Level May Influence Brain Tumor Risk

Obesity, Physical Activity Level May Influence Brain Tumor Risk

By

Researchers found an association between obesity and meningioma risk, but not for glioma.

Combination Therapy May Eradicate Glioblastoma Cells

Combination Therapy May Eradicate Glioblastoma Cells

By

The combination therapy specifically targets glioblastoma cells.

Glioma Patients May Be Good Candidates for Single-Agent Phase 1 Trials

Glioma Patients May Be Good Candidates for Single-Agent Phase 1 Trials

Patients who meet standard eligibility requirements may make good candidates for single-agent trials.

Trends in Glioma Treatment Show Increased Survival Rates

Trends in Glioma Treatment Show Increased Survival Rates

Researchers found a decrease in use of radiation treatment after 2005.

Glioma Subtypes Identified Through Genomic Alterations

Glioma Subtypes Identified Through Genomic Alterations

Two studies classified gliomas into distinct subtypes by analyzing their genomes.

Contraceptive Use May Raise Risk of Rare Brain Tumor

Contraceptive Use May Raise Risk of Rare Brain Tumor

The researchers stressed that gliomas are very rare, and risk/benefit still favors using hormonal contraception.

Bevacizumab is Safe, Effective for Recurrent Glioblastoma

Bevacizumab is Safe, Effective for Recurrent Glioblastoma

70.8% of patients saw improved performance status while on single-agent bevacizumab.

Chemotherapy Slows Glioma Progression After Radiation

Chemotherapy Slows Glioma Progression After Radiation

Procarbazine, CCNU, and vincristine administered after radiation therapy was shown to improve survival in gliomas.

Brittany Maynard's 'Death with Dignity' Poses Challenge to Hippocratic Oath

Brittany Maynard's 'Death with Dignity' Poses Challenge to Hippocratic Oath

By

Brittany Maynard's physician-assisted suicide has reignited the "death with dignity" debate that challenges the ethical standards of the medical profession.

Sign Up for Free e-newsletters



CME Focus